Jingrong Jean Cui, Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 48,500 shares at $57.76 ($3.0M) on 2019-12-18, disclosed to the SEC on 2019-12-20.
Open-market sale of $3.0M TPTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.76 | 3,730 | $215K | 7.3% |
| 2 | $58.48 | 3,898 | $228K | 7.7% |
| 3 | $59.78 | 7,802 | $466K | 15.8% |
| 4 | $60.38 | 3,070 | $185K | 6.3% |
| 5 | $59.84 | 1,400 | $84K | 2.8% |
| 6 | $60.69 | 9,230 |
| $560K |
| 19.0% |
| 7 | $61.48 | 4,970 | $306K | 10.3% |
| 8 | $62.33 | 2,900 | $181K | 6.1% |
| 9 | $62.64 | 1,400 | $88K | 3.0% |
| 10 | $63.42 | 8,500 | $539K | 18.2% |
| 11 | $63.99 | 1,600 | $102K | 3.5% |
| Total | $60.92 avg | 48,500 | $3.0M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |